---
figid: PMC4314580__emm2014105f4
figtitle: Treatment strategies for inactivating EBV infection or EBV-associated oncogenic
  pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC4314580
filename: emm2014105f4.jpg
figlink: /pmc/articles/PMC4314580/figure/fig4/
number: F4
caption: Treatment strategies for inactivating EBV infection or EBV-associated oncogenic
  pathways. (1) Conventional chemotherapeutic agents or radiation target DNA. (2)
  Different strategies to disrupt microRNAs can be offered. (3) EBV-specific cytotoxic
  T cells are used as an immunoregulatory therapeutic approach. (4) Agents can target
  the lytic cycle of EBV. Agents targeting the (5) NF-kB pathway, (6), PI3K/Akt pathway,
  (7) PKC pathway, (8) MAPK pathway, (9) Lyn or (10) Sky can be tried. The monoclonal
  antibody SGNE-35 targets (11) CD30.
papertitle: Epsteinâ€“Barr virus-positive T/NK-cell lymphoproliferative disorders.
reftext: Qingqing Cai, et al. Exp Mol Med. 2015 Jan;47(1):e133.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9522377
figid_alias: PMC4314580__F4
figtype: Figure
redirect_from: /figures/PMC4314580__F4
ndex: bee0cf27-def1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4314580__emm2014105f4.html
  '@type': Dataset
  description: Treatment strategies for inactivating EBV infection or EBV-associated
    oncogenic pathways. (1) Conventional chemotherapeutic agents or radiation target
    DNA. (2) Different strategies to disrupt microRNAs can be offered. (3) EBV-specific
    cytotoxic T cells are used as an immunoregulatory therapeutic approach. (4) Agents
    can target the lytic cycle of EBV. Agents targeting the (5) NF-kB pathway, (6),
    PI3K/Akt pathway, (7) PKC pathway, (8) MAPK pathway, (9) Lyn or (10) Sky can be
    tried. The monoclonal antibody SGNE-35 targets (11) CD30.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PDLIM7
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - NFKB1
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - LYN
  - SYK
  - TP53
  - TP63
  - TP73
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - BCR
  - RN7SL263P
  - MDM2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - TNFRSF8
  - rela
  - lyn
  - si:ch73-206d17.1
  - syk
  - tp53
  - bcr
  - mdm2
  - Ly294002
  - romidepsin
  - Pralatrexate
  - Bosutinib
  - Saracatinib
  - Fostamatinib
  - BEZ235
  - Acyclovir
  - 5-Azacytidine
  - Doxorubicin
  - Phorbol ester
  - Rapamycin
  - Sodium butyrate
  - Cancer
---
